6-Imino-2-thioxo-pyrimidinones as a new class of dipeptidyl peptidase IV inhibitors

被引:2
|
作者
Jelic, Dubravko [1 ]
Nujic, Krunoslav [1 ]
Stepanic, Visnja [1 ]
Kovacevic, Krunoslav [1 ]
Verbanac, Donatella [1 ]
机构
[1] GlaxoSmithKline Res Ctr Zagreb Ltd, Zagreb 10000, Croatia
关键词
DPP IV inhibitor; Pyrimidinone; Enzyme kinetics; Molecular docking; Cytotoxicity; GENETIC ALGORITHM; VALIDATION; EXPRESSION; THERAPY; DOMAIN;
D O I
10.1007/s00044-010-9314-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dipeptidyl peptidase IV is a glycoprotein which removes N-terminal dipeptides from physiologically relevant polypeptides. An homologous series of 6-imino-2-thioxo-5-{[3,4,5-tris(methyloxy)phenyl]methyl}-2,5-dihydro-4(3H)-pyrimidinones has been tested for inhibition of DPP IV activity. The inhibitory effects at 0.1 mM were observed. Enzyme kinetic studies revealed that compounds inhibit DPP IV activity competitively. According to the molecular docking analysis, the inhibitors are anchored into the DPP IV hydrolytic site by interactions of the pyrimidinone core with Glu206, Tyr662, and Tyr547, with the alkyl chain entering the S1 pocket. We conclude that pyrimidinone-like compounds are a promising new scaffold for reversible inhibition of DPP IV.
引用
收藏
页码:339 / 345
页数:7
相关论文
共 50 条
  • [1] 6-Imino-2-thioxo-pyrimidinones as a new class of dipeptidyl peptidase IV inhibitors
    Dubravko Jelić
    Krunoslav Nujić
    Višnja Stepanić
    Krunoslav Kovačević
    Donatella Verbanac
    Medicinal Chemistry Research, 2011, 20 : 339 - 345
  • [2] New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
    Cui, Chenkai
    Tian, Xuefei
    Wei, Linting
    Wang, Yinhong
    Wang, Kexin
    Fu, Rongguo
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors
    A. J. Scheen
    Diabetologia, 2012, 55 : 2848 - 2849
  • [4] Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors
    Scheen, A. J.
    DIABETOLOGIA, 2012, 55 (10) : 2848 - 2849
  • [5] Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
    Yazbeck, Roger
    Howarth, Gordon S.
    Abbott, Catherine A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (11) : 600 - 607
  • [6] The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases
    Augustyns, K
    Van der Veken, P
    Senten, K
    Haemers, A
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (08) : 971 - 998
  • [7] Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration
    Kondo, Takashi
    Nekado, Takahiro
    Sugimoto, Isamu
    Ochi, Kenya
    Takai, Shigeyuki
    Kinoshita, Atsushi
    Tajima, Yohei
    Yamamoto, Susumu
    Kawabata, Kazuhito
    Nakai, Hisao
    Toda, Masaaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) : 2631 - 2650
  • [8] Recent Medicinal Chemistry Approach for the Development of Dipeptidyl Peptidase IV Inhibitors
    Shah, Bhumi M.
    Modi, Palmi
    Trivedi, Priti
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (18) : 3595 - 3621
  • [9] Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV
    Alonso, Isel Pascual
    Valiente, Pedro A.
    Valdes-tresanco, Mario E.
    Arrebola, Yarini
    Garcia, Fabiola Almeida
    Diaz, Lisset
    Garcia, Gabriela
    Guirola, Osmany
    Pastor, Daniel
    Bergado, Gretchen
    Sanchez, Belinda
    Charli, Jean-Louis
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 196 : 120 - 130
  • [10] Design and synthesis of long-acting inhibitors of dipeptidyl peptidase IV
    Kondo, Takashi
    Sugimoto, Isamu
    Nekado, Takahiro
    Ochi, Kenya
    Ohtani, Tazumi
    Tajima, Yohei
    Yamamoto, Susumu
    Kawabata, Kazuhito
    Nakai, Hisao
    Toda, Masaaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) : 2715 - 2735